and the tragedy of Lear, has no words for the shiver and the headache. It has all grown one way.
'The merest schoolgirl when she falls in love has Shakespeare or Keats to speak for her but let a sufferer try to describe a pain in his head to a doctor and language at once runs dry' (Virginia Woolf: 'On Being Ill').
'From a semantic point of view this might be called a symposium upon a hyphenthe hyphen in the bodymind relationship' (Lord Brain).
About two hundred years ago, on September 3, 1773, Dr John Coakley Lettsom, the founder of the Medical Society of London, read a paper before that Society entitled 'The Cause of Pain in Rheumatism'. I therefore have a good classical precedent for the topic I have chosen for my Address. Unfortunately the text of Lettsom's lecture appears to have been lost to posterity for it would surely have been fascinating, if perhaps rather disturbing, to discover what the medical elite of two hundred years ago were thinking about the cause of rheumatic pains and to appreciate how little apparent progress we have made in the ensuing period.
As rheumatologists, we are entitled to claim a special concern with pain mechanisms, and it is both humiliating and frustrating to have to admit that a high proportion of patients attending our clinics with pains which, for convenience, we categorize as 'nonarticular rheumatism', defy accurate anatomical or pathological diagnosis. If we apply strict objective criteria I believe that the percentage who are thus unsatisfactorily diagnosed might comprise up to a third of all those problems with which we are daily faced. As a result, we are all too often forced to resort to such imprecise terminology as 'functional' or 'psychogenic' overlay. Such labels, unless they are based on positive evidence, may represent a refuge for our ignorance and, whilst recognizing fully the importance of psychosomatic mechanisms, I often feel it would be salutary if we were to impose a ban on their use in the absence of unequivocally positive psychiatric evidence which we seldom have time to obtain.
Previous generations of rheumatologists were, because of technical limitations, denied facilities for basic research and, as a result, they tended to advance unscientific and untenable hypotheses in order to explain their patients' suffering. I believe that the tide is now turning with regard to techniques of basic research and that it is therefore incumbent upon our generation to study and to try to interpret any contributions made by research colleagues, however obliquely they appear to refer to our clinical problems. I also believe that we have a responsibility as clinicians to organize dependable clinical research projects in an effort to sort out the morass of conflicting evidence in this sphere.
In this Address, therefore, I propose to examine a few hypotheses which I have developed on the basis of twenty-one years of clinical experience and to try to relate these concepts to experimental evidence provided mainly by pathologists, pharmacologists and neurophysiologists.
Referred Pain and Fibrositis I shall focus most of my attention on the relationship between centrally (or viscerally) induced pains which are referred to the musculoskeletal system and present to the clinician under the general and colloquial classification of 'fibrositis'. In effect, I am resurrecting once again the question whether there is a peripheral pathology for 'fibrositis'. If so, it seems important to consider whether this can be a primary pathology or whether it is always the secondary manifestation of a neurophysiological stimulus. If it could be proved that peripheral areas of referred pain have a specific, if secondary, pathology, many hitherto inexplicable clinical problems would be elucidated. Furthermore the dichotomy between physicians, who tend to dismiss the likelihood of structural pathology, and our physiotherapeutic colleagues, who spend so much of their time treating notional peripheral lesions, would be nearer to solution.
Each of us could produce a host of patients who have undoubted spondylotic lesions producing exclusively peripheral symptoms. Frequently one is forced by therapeutic desperation to treat such patients' symptoms by means of infiltration with local anaesthetics and corticosteroids. It is my contention that the proportion of successes from such an apparently illogical treatment is far higher than could be accounted for by statistical chance. It is also my experience that, in certain circumstances, the inclusion of corticosteroids with the local aniesthetic increases the likelihood of success with such injections. It is true that one seldom achieves permanent cure, but it is not uncommon to obtain relief for upwards of three months provided that the painful area is accessible to a needle and is diligently covered. These injections are extremely painful and it is difficult to believe that sensible patients would return at regular intervalsand frequently against adviceunless they obtained worth-while benefit.
Early and Late Stages of Referred Pain It seems possible that as a result of central nervous irritation a potentially reversible lesion is produced in the peripheral musculoskeletal tissues. The exact nature of this peripheral lesion remains elusive, but it seems to progress through two distinct phases and failure to appreciate this has, I believe, resulted in confused thinking in the past. I shall designate these as the 'early', as opposed to the 'late', phases of referred pain.
The favourite hypothesis to explain 'early' referred pain is that it is due to muscle spasm leading to muscle ischmmia and the consequent accumulation of pain-producing metabolites. Indeed, I listened with great interest in 1966 to a Presidential Address to the Section of Orthopmdics of this Society by Mr St Clair Strange entitled 'Debunking the Disc'. His main theme was that primary muscle spasm was the cause of most types of backache, and that by the simple expedient of pressing very hard with one's thumbs on such areas of spasm, the pains could be relieved with remarkable consistency. I believe that his observation may be correct, but that it applies only in the early and acute phase of referred pain. I also believe that at this stage one could equally well relieve the spasm with a local anesthetic infiltration to which the addition of corticosteroids would make no discernable difference. However, the concept of muscle spasm is inadequate to explain more chronic types of referred pain as proved by Taverner in 1954. He was able to exclude significant muscle spasm in those cases of 'fibrositis' which he investigated by electromyography; indeed he showed that such pain was usually due to fatigue rather than to spasm.
Pathology ofFibrositis
It is true that since Stockman's (1920) description of an inflammatory infiltration in fibrositic areas was discounted by later workers there has been a remarkable paucity of evidence for a structural lesion as an explanation of chronic soft-tissue 'rheumatism'. But I believe that a paper originally published in 1957 by Brendstrup et al. has received less attention than it deserves. This group took 12 symmetrical biopsy specimens from chronic 'fibrositic' areas in the sacrospinales muscles of patients operated on for herniated discs. They make the point that since these specimens were taken when the patients were fully an&sthetized and relaxed with curare the concept of muscle spasm could be confidently eliminated. Nevertheless, they found a striking difference between the microscopic pictures of the fibrositic specimens and those of the controls indicating, they claim, a morphological basis for the palpatory findings of the fibrositic tissues. The changes demonstrated consisted of interstitial mucinous edema containing acid mucopolysaccharides and an accumulation of mast cells, which are generally considered to be the origin of the mucopolysaccharide ground substance. The biochemical analysis bore out the microscopic observations. Thus the hexosamine concentration as well as the content of hyaluronic acid was significantly higher than in the controls. Hyaluronic acid has a strong water-binding capacity and accordingly the fluid content of the fibrositic muscles was found to be 8 % higher than in the controls. The extracellular space had increased to about 15 % of the muscle volume, the intracellular space being correspondingly decreased, as revealed by potassium determinations. Boas & Foley (1954) found that both mechanical and chemical irritation of connective tissue causes an increase of hexosamine concentration. The increase in the extracellular fluid constitutes in effect an cedema of the connective tissue which may well cause pain by distension or distortion of peripheral neurones (Wegelius & Asboe-Hansen 1956). If such interstitial and mucinous cedema persists it might well lead to a reactionary fibrosis and contracture of the connective tissue, such for example as one sees when an acute periarthritis of the shoulder gradually develops a constrictive capsulitis.
Etiology of Fibrositis
It seems likely that musculoskeletal pathology arises from a wide variety of insults including traumaf ischmmia, toxins or exposure to thermal extremes. Usually such 'insults' cause painful lesions which have a strong tendency to heal spontaneously. However, in the elderly and in sufferers from chronic rheumatic pains there appears to be a constitutional abnormality of the connective tissue enabling such trivial lesions to perpetuate themselves until they become chronic. There is probably a common end-pathology to all these painful lesions, irrespective of the mechanism by which they are produced.
Physiologists have described at least two neurological mechanisms which may cause stimuli of visceral origin to be misinterpreted as musculoskeletal pain. The first involves the antidromic misrooting of stimuli down common branched axons, the second involves the phenomenon of the 'summation' of multiple stimuli arising within the same sclerotome of the spinal cord (Weddell 1957) .
Disc Pathology and Symptomatology
Musculoskeletal pain of visceral origin is manifestly less important to our immediate theme than so called 'discogenic' pains. Indeed, in rheumatology we can seldom afford to ignore the ubiquitous and versatile presentation of discinduced pains when considering our differential diagnosis.
In a normal disc the weight is distributed uniformly throughout its surface area, largely because of the fluid nature of the nucleus. Motion is about a fixed axis. As soon as the hydraulic function of the disc is lost, however, it is the fibrous annulus which is called upon to bear all the weight and this is now concentrated in areas instead of being evenly distributed. Therefore motion becomes abnormal. Symptoms may be produced by abnormal motion and resulting abnormal strains between adjacent vertebre. These strains are followed by the formation of reactive scar tissue and osteophytes. Any movement which now occurs outside the limits imposed by this scar tissue results in a 'sprain' or microrupture of this vulnerable and pain-sensitive tissue, and it is not difficult to understand how this may reinforce and perpetuate local pain. Cloward (1959) demonstrated how such local stimuli could be referred to specific peripheral areas of the musculoskeletal system. He reported extensively on the results he obtained in the course of performing discography. Subsequent observations were made following the stimulation of various structures in the cervical spines of patients undergoing operations to fuse their cervical spines by the anterior approach under local anesthesia. Using such techniques he was able to build up consistent and extremely elegant pain maps according to the exact structure which he stimulated with his blunt probe. He described essentially three different types of pain according to the structure stimulated: (1) Discogenic, arising from the irritation of the ligaments and other pain-sensitive structures in direct relationship to the disc. (2) Neurogenic, resulting from irritation of the nerve root or its dural sheath.
(3) Myelogenic, resulting from a mid-line lesion pressing on the spinal cord or its meninges.
Not only did Cloward demonstrate specific anatomical distributions of the pain depending on the points stimulated but he also described important qualitative differences in the type of pain of which the patients complained. Thus, pain arising from irritation of the anterior nerve root consisted of a deep burning or boring sensation associated with diffuse tenderness of sclerotome distribution. If, however, the sensory root was stimulated the patient complained of lightning-like pains which were well defined and in dermatome distribution. Cloward (1960) concluded that true discogenic pain arises from irritation of the sinu-vertebral nerve, which was originally described by Luschka in 1850. This nerve anastomoses freely with corresponding nerves of adjacent vertebrae. It is therefore not surprising that frequently pain from a single disc lesion is not localized to one dermatome and may indeed be surprisingly diffuse. The main filament of the nerve passes through the spinal cord as a reflex arc and exits with the anterior nerve root, which also receives filaments from the sympathetic chain via the grey rami communicantes.
It is evident from clinical experience that discogenic, neurogenic and myelogenic types of pain are not mutually exclusive. Indeed they commonly occur simultaneously or consecutively in the same patient. However, it seems to be the discogenic pain pattern which is responsible for musculoskeletal pains referred to the trunk. We know that the nucleus pulposus varies considerably in size and tension according to its osmotic equilibrium, and swelling may eventually cause microfissures in the annulus fibrosus with secondary congestion and cedema in the surrounding ligaments. Such pathology might well stimulate the peripheral nerves via the sinu-vertebral nerve. The anatomical contiguity of the sympathetic pathway is also of interest because there usually seems to be a vasomotor element in painful connective tissue lesions.
Section ofPhysical Medicine
Physiology of the Autonomic Nervous System Loewenstein (1956) provided evidence of the importance of the sympathetic nerve supply in his experiments on isolated frog's skin. Sympathetic nerve stimulation lowered the response threshold of the skin tactile receptors to any mechanical stimulation and eventually led to spontaneous activity in these receptors. (A similar observation was made by Claude Bernard in experiments on cats in 1851.) Apparently then, adrenergic stimuli potentiate the threshold response levels of tactile receptors and eventually cause them to fire off spontaneously. Bulbring & Burn (1941) demonstrated that adrenaline can sensitize nerve synapses to the effect of acetylcholine. Since acetylcholine is itself a pain-producing substance this observation could be significant.
As the adrenaline-sensitizing effect is increased the insulation of the entire nerve may break down so that stimuli can pass directly from one nerve fibre to the adjacent one. It seems possible that causalgia and various reflex dystrophies are the clinical analogues of this phenomenon.
The Interpretation of Tenderness and Needle Soreness Peripheral tenderness as opposed to spontaneous pain is, I believe, a physical sign deserving further consideration. In Table 1 the manifestations of referred pain and tenderness, as found in the early and late phases, are classified and contrasted. During the early phase, referred pain and tenderness can usually be rapidly and totally relieved by treatments applied to the spinal source of the pain, whether by immobilization, traction, manipulation or other techniques. It is probably at this phase, for example, that osteopaths achieve their 'instant cures'. Conversely, at this early stage, treatment applied to the area of referred pain yields only temporary or partial relief.
Tenderness to deep pressure in the early phase usually causes a graduated increase in the intensity of the discomfort, as opposed to the explosive and often unbearable crescendo of pain which may occur when pressure is applied in the late phase. Early tenderness is usually localized in the area in which the patient perceives his pain but in the late stage the patient may be quite unaware of the site of his maximum tenderness until it is elicited by the examiner. In the early stage deep pressure on the tender spot causes exclusively local discomfort whereas in a late case it is frequently possible to produce a radiation of pain which mimics the patient's presenting symptoms.
Likewise, needle exploration in the early phase is relatively painless, whereas in the late phase the patient can quickly and easily localize the point at which the needle causes a feeling of soreness often described as a sensation of 'bruising'.
In parenthesis, I do not agree, from my experience, that normal deep fascia or periosteum are painful to needle exploration despite the repeated assertion to the contrary in textbooks.
Local anesthetics infiltrated in the early phase may abolish skin hypertsthesia but seldom influence the underlying spontaneous pain. Furthermore, at this stage the abolition of one area of tenderness frequently reveals another which was not apparent before. By contrast, in the late stage, local anesthetic infiltration may achieve a total and immediate suppression of symptoms and signs. The addition of crystalline corticosteroids at this stage will materially improve the chances of long-term relief (although the pain may increase during the first 48 hours due to the irritant effect which the crystals sometimes produce on the connective tissues).
Cellular Pathology and Fibrositis
On the basis of this, admittedly circumstantial, evidence it seems reasonable to postulate two phases of referred pain. In the first phase, the symptoms may be produced by a pain-producing metabolite which is released at the nerve endings into the connective tissues. Such a metabolite, if it is not immediately leached out of the area, could produce local tissue irritation which in its turn results in cellular damage and the release of intracellular cathepsins, possibly from mast cells or from the connective tissue cells themselves. The potential response of the connective tissue cells to this type of enzymatic insult is probably limited. Indeed, it may well be identical to a wide range of provocations, whether these be neurogenic, traumatic, ischimic, thermal or toxic.
Naturally occurring pain-producing factors include: Histamine, 5-hydroxytryptamine, acetylcholine, plasma kinins, adenosine triphosphatase, potassium ions, lactic acid, Lewis's 'P' substance, neurokinin ('headache substance'), hypertonic and hypotonic solutions, acid or alkaline solutions.
In other words, it seems likely that the final common pathway by which all these diverse stimuli cause tissue damage is by the release of intracellular cathepsins. It is recognized that there are many intracellular enzymes which are quite innocuous when contained within the confines of the cell but extremely irritant when released into the tissue spaces. These cathepsins are capable of denaturing the mucopolysaccharide of ground substance which may well produce a picture similar to that already noted when describing Brendstrup's histochemical studies. It has been demonstrated by Fell & Dingle (1963) that lysosomal enzymes can cause extensive degradation to articular cartilage so it seems possible that they may have a similar effect on other types of connective tissue. The clinical expression of this concept would be the delayed pain which occurs after an apparently trivial injury. The immediate results of such an injury may be so slight that they are ignored but about 48 hours later the patient may develop a progressively painful and self-perpetuating soft-tissue lesion.
From a personal experience in which I was induced to inject a solution of colchicine into my own soft tissues for medico-legal purposes I can vouch that this course of events can occur following a chemical irritant. Thus, the initial impact of my injection was negligible, but 48 hours later the pain became intense and lasted for many days. It is easy to imagine situations in which such connective tissue lesions do not resolve themselves but become self-perpetuating. Indeed, such an artificial lesion might prove to be an excellent experimental model for the production of soft-tissue rheunmatic pains.
Pharmacology ofCorticosteroids
Having expressed my conviction that locally injected corticosteroids produce clinical benefit, at any rate in the established 'fibrositic' lesion, a study of their pharmacology in relation to the connective tissues should prove rewarding. Yet despite twenty years of prodigious research we have not managed to discover their fundamental mode of action at the cellular level. It must indeed be a very subtle mechanism because cortisone itself when injected locally has no detectable effect, whereas the simple substitution of a hydroxyl group in the eleven position of the steroid nucleus renders hydrocortisone and all its subsequent derivatives intensely anti-inflammatory on local administration. Table 2 lists some of the known actions of corticosteroids. Table 2 Actions of corticosteroids on connective tissue Inhibition of mitosis Inhibition of production of collagen and homogenization of collagen fibres Decrease in number of mast cells Decrease in size and number of fibroblasts Decrease in permeability of connective tissue Decreased synthesis of polymerization of hyaluronic acid Decrease in water-binding capacity and in reactive amino groups Reduction of aminotripeptidase activity Decrease in metachromatic staining of connective tissue Stabilization of lysosomal membranes Reduction of intra-articular temperature in inflamed joints It is notable that one of the well-described pharmacological mechanisms is the stabilization of lysosomal membranes inhibiting the release of their enzymes. It seems quite likely that this is a primary action on connective tissue and that the other pharmacological mechanisms are secondary. For example, by the inhibition of oedema, of fibrin deposition, of the migration of phagocytes and of capillary dilatation, corticosteroids would be expected to suppress inflammation. However, this inflammation would inevitably return unless the release of intracellular cathepsins could be inhibited for a sufficiently long time to enable natural healing processes to supervene to completion. In addition, corticosteroids inhibit secondary cicatrization and they would limit contractures in the healing phase. Corticosteroids, therefore, should, and do, yield a nonspecific benefit on inflammation whether this arises on a chemical or an immunological basis.
Neurogenic and Psychogenic Influence Any account, however fanciful, of the production ofsoft-tissue rheumatic pains is incompleteuntil the pain impulses are traced through the brain istem and thalamus to the cortex, because it is evident that the clinical significance of the pathology I have described is subsidiary to the patient's pain perception and 'complaint threshold'. This depends on complex modifications of the impulses as they traverse the brain stem and ultimately on psychogenic factors as they enter consciousness. In relation to the brain-stem modifications, I would like to commend the interesting 'gate' theory of Melzack & Wall (1965) which gives a plausible explanation of several aspects of pain sensation which are otherwise quite perplexing.
With regard to psychogenic influences, I will briefly mention three personal convictions:
(1) It seems beyond dispute that endogenous depression plays an important part in influencing a patient's complaint threshold. As a corollary I find an ever-increasing use for the antidepressive groups of drugs in my clinical practice. I tend to favour the monoamine-oxidase inhibitor group for these patients although I could not substantiate this preference statistically.
(2) The influence of anxiety and tension on skeletal pain production is, I believe, indisputable. Again I am led to wonder whether noradrenaline could be the linch-pin in the psychosomatic chain of events. In this connexion I was interested recently to hear a report about a series of patients with classical anxiety states, some of whom manifested skeletal pains and were treated most successfully with beta-adrenergic blocking agents (Suzman, personal communication).
(3) The third important psychogenic mechanism which I wish to invoke is that of distraction. This was well illustrated by an actress who was suffering agonizing arthritic pains and requested temporary relief during the limited season during which she was inescapably committed to perform nightly. Analgesic drugs had proved quite ineffective in her case but, in the event, she told me that from the moment she stepped on to the stage and throughout the whole length of her exacting roles in the various productions she was conscious of no pain whatever. It is probable that faith healing and hypnotherapy relieve pain by similar mechanisms and it may be that Melzack & Wall's ingenious 'gate theory' provides a plausible explanation as to how pain sensations can be cut off from the cortex by the metaphorical 'closing of the gate'.
Future Investigations
My motive in choosing this difficult subject for my Presidential Address was the hope of pro-voking controversy or, even better, experimentation designed to prove or disprove some of the concepts which, with considerable temerity, I have put forward. I would like to conclude by suggesting one or two lines of research which seem to me to be practicable and potentially useful. It should be possible, for example, to localize by the injection of a dye such as methylene blue, the sites oforigin ofnonarticular pains. This would enable accurate biopsies to be taken. My observations about the significance of 'needle soreness', if they are correct, should make this a relatively simple procedure.
If this could be done, biopsies taken before and after corticosteroid injections should yield important information as to the anti-inflammatory pharmacology of these substances. Such biopsy material would be submitted not only to routine staining and microscopy but also to electron microscopy and detailed histochemical and biochemical analysis. Specifically, various acknowledged pain-producing metabolites and enzymes could be searched for. Conversely a study of the effect of such substances when applied in vitro to biopsy specimens might be rewarding.
Then I would suggest an in vivo experiment using a chemical irritant (possibly colchicine in view of my own experience) in order to produce experimental painful connective tissue lesions in animals. Such lesions could be studied sequentially at varying periods following the injection; if recognizable changes occurred we would have a simple experimental model on which to test the 'antirheumatic' drugs of the future.
Cloward's observations on neurogenic stimuli seem to be another obvious hunting ground for the experimental physiologist. For example, we require to know what happens at the peripheral nerve end-plate when a stimulus is applied centrally. It should be possible to determine the nature of any metabolite which is released peripherally and to study how the connective tissue fesponds to it. Following this, various drugs which are capable of blocking humoral release mechanisms could be tried experimentally and eventually clinically. I would also like to follow the implications of a personal observation (Glyn et al. 1966) in which it was reported that a joint deprived of its motor innervation seems to be spared those ravages of destructive arthritis characteristic of joints deprived of their sensory or autonomic supply (i.e. Charcot joints). This is a most fascinating observation, especially since such weight-bearing joints are not only spared from structural arthritis but also remain remarkably painless, despite the intense mechanical strains to which their capsules and ligaments are usually subjected, following, for example, a disease such as poliomyelitis. It should not be impossible to produce experimental evidence as to how this selective denervation protects connective tissues in situations which would otherwise result in painful joint pathology.
Muscle spasm, the accumulation of muscle metabolites and various vasomotor influences are other concepts deserving of further study possibly employing the techniques of electromyography, thermography or even radioisotope scanning. Such studies, even if they proved negative, would pay for themselves many times over by the elimination from the market of scores of seemingly useless muscle relaxant and vasodilator drugs in the therapy of nonarticular rheumatism.
Finally, I remain intensely curious about the genesis of such common and accessible pathology as periarthritis and capsulitis of the glenohumeral joint and the so-alled 'tennis elbow'. In so far as some of these cases appear to be secondary to cervical spon7dylosis causing central neurogenic irritation, I wondered if it would be possible to exteriorize the phrenic nerve of a suitable animal and so to apply repetitive stimuli whilst studying any changes in the biochemistry or histology of the capsule of the shoulder and elbow joint. If it proved possible to produce remote pathology in this way an experimental model for the study of various therapeutic approaches would be available.
Conclusion
My final thought is that nonarticular rheumatic pains, as judged by a simple count of the number of sufferers, present us with a vital challenge which has been ignored over the years, largely it seems to me for want of a satisfactory 'point of entry'. I believe that the challenge could be successfully resolved if a fraction of the time, money and energy now being applied to the investigation and treatment of the arthritic group of rheumatic diseases were diverted to the systematic investigation of 'soft tissue' rheumatism.
